The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
Lie, Ingrid Anne; Wesnes, Kristin; Kvistad, Silje S.; Brouwer, Iman; Wergeland, Stig; Holmøy, Trygve; Midgard, Rune; Bru, Alla Nikolajevna S; Edland, Astrid; Eikeland, Randi; Gosal, Sonia; Harbo, Hanne-Cathrin Flinstad; Kleveland, Grethe; Sørenes, Yvonne; Øksendal, Nina; Barkhof, Frederik; Vrenken, Hugo; Myhr, Kjell-Morten; Bø, Lars; Torkildesen, Øivind
Peer reviewed, Journal article
Published version
Permanent lenke
https://hdl.handle.net/11250/3043107Utgivelsesdato
2022Metadata
Vis full innførselSamlinger
Originalversjon
Lie, I. A., Wesnes, K., Kvistad, S. S., Brouwer, I., Wergeland, S., Holmøy, T., Midgard, R., Bru, A. N. S., Edland, A., Eikeland, R., Gosal, S., Harbo, H.- C. F., Kleveland, G., Sørenes, Y., Øksendal, N., Barkhof, F., Vrenken, H., Myhr, K.- M., Bø, L. & Torkildesen, Ø. (2022). The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. Neurology: Neuroimmunology and neuroinflammation, 9 (5). https://doi.org/10.1212/NXI.0000000000200008Sammendrag
The relationship between smoking, long-term brain atrophy, and clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed long-term effects of smoking by evaluating MRI and clinical outcome measures after 10 years in smoking and nonsmoking patients with relapsing-remitting MS (RRMS).